EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol

Jeremy C Reitinger, David M Reed iD, Cameron Peres iD, Shan Fan, Vikas Gulati, Arash Kazemi, Arthur J Sit, Sayoko E Moroi iD, Carol B Toris iD

Journal of Ocular Pharmacology and Therapeutics · 2025

DOI: 10.1089/jop.2024.0112 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2025. Verfasst von Jeremy C Reitinger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana. Hauptthemen laut MEDLINE: Latanoprost, Timolol, Intraocular Pressure, Antihypertensive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To identify reasons for variable intraocular pressure (IOP) responses to latanoprost and timolol in healthy volunteers and to generate the control group as part of Eye Dynamics and Engineering Network.

Methods

In this multicenter, randomized, crossover study (NCT01677507), both eyes of 106 healthy subjects (212 eyes) were treated with latanoprost or timolol for 7 days, with a 6-week washout between treatments. Ocular biometrics, tonometry, and aqueous humor dynamics (AHD) were assessed at baseline and day 8 of each treatment. Subjects were divided into responders and nonresponders using cutoffs of >15% or >10% IOP reduction. Treatment effects and correlations were analyzed with paired t-tests.

Results

More subjects responded to latanoprost (54%) than timolol (27%) at >15% cutoff (p < 0.01). Responders had higher mean baseline IOP than nonresponders for both drugs at both cutoffs (p < 0.01). Among timolol nonresponders (n = 56), 39% responded to latanoprost in both eyes, 20% in one eye, and 41% in neither. Among latanoprost nonresponders (n = 31), 13% responded to timolol in both eyes, 13% in one eye, and 74% in neither. Latanoprost increased uveoscleral outflow, while timolol reduced aqueous flow and outflow facility. Low baseline uveoscleral outflow was associated with latanoprost response.

Conclusions

Higher baseline IOP predicted better responses to both drugs. Higher baseline uveoscleral outflow predicted nonresponse to latanoprost. No AHD differences were linked to the timolol response. Timolol nonresponders were often responsive to latanoprost, but not vice versa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LatanoprostTimololIntraocular PressureAntihypertensive AgentsProstaglandins F, SyntheticHumansCross-Over StudiesMaleFemaleAdultMiddle AgedTonometry, OcularAqueous HumorAgedYoung Adult

Stichwörter der Autor:innen

aqueous humor dynamicsglaucomaintraocular pressurelatanoprosttimolol

Substanzen

LatanoprostTimololAntihypertensive AgentsProstaglandins F, Synthetic

Autor:innen und Institutionen

  • Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Department of Ophthalmology and Visual Sciences, The Ohio State University, Columbus, Ohio.
  • Department of Ophthalmology and Visual Sciences, Stanley M Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska.
  • Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
  • Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.

ORCID-Profile: David M Reed, Cameron Peres, Sayoko E Moroi, Carol B Toris

Förderung

  • NEI NIH HHS

Zitieren

APA

Reitinger, J. C., Reed, D. M., Peres, C., Fan, S., Gulati, V., Kazemi, A., Sit, A. J., Moroi, S. E., & Toris, C. B. (2025). Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0112

Vancouver

Reitinger JC, Reed DM, Peres C, Fan S, Gulati V, Kazemi A, et al. Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol. Journal of Ocular Pharmacology and Therapeutics. 2025. doi:10.1089/jop.2024.0112

BibTeX
@article{Reitinger2025,
  author = {Reitinger, Jeremy C and Reed, David M and Peres, Cameron and Fan, Shan and Gulati, Vikas and Kazemi, Arash and Sit, Arthur J and Moroi, Sayoko E and Toris, Carol B},
  title = {Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1089/jop.2024.0112}
}
Kostenlos starten →